I. Expression across cell types
Name | Number of supported studies  | Average coverage | |
|---|---|---|---|
| plasmacytoid dendritic cell | 11 studies | 37% ± 10% | |
| B cell | 8 studies | 23% ± 6% | |
| regulatory T cell | 8 studies | 20% ± 3% | |
| conventional dendritic cell | 6 studies | 28% ± 12% | |
| non-classical monocyte | 6 studies | 20% ± 6% | |
| classical monocyte | 5 studies | 19% ± 2% | |
| memory B cell | 5 studies | 20% ± 3% | |
| CD8-positive, alpha-beta T cell | 5 studies | 18% ± 5% | |
| hematopoietic precursor cell | 4 studies | 25% ± 9% | |
| epithelial cell | 4 studies | 29% ± 12% | |
| CD16-negative, CD56-bright natural killer cell, human | 4 studies | 22% ± 4% | |
| natural killer cell | 4 studies | 24% ± 3% | |
| effector CD8-positive, alpha-beta T cell | 4 studies | 17% ± 1% | |
| dendritic cell | 4 studies | 32% ± 15% | |
| naive B cell | 4 studies | 20% ± 2% | |
| naive thymus-derived CD8-positive, alpha-beta T cell | 3 studies | 19% ± 2% | |
| precursor B cell | 3 studies | 21% ± 4% | |
| immature B cell | 3 studies | 21% ± 5% | |
| endothelial cell | 3 studies | 24% ± 8% | |
| effector CD4-positive, alpha-beta T cell | 3 studies | 20% ± 3% | |
| hematopoietic stem cell | 3 studies | 22% ± 2% | |
| CD4-positive, alpha-beta memory T cell | 3 studies | 17% ± 2% |
